Effects of Oral Supplementation with Pyrroloquinoline Quinone on Stress, Fatigue, and Sleep

Authors

  • Masahiko Nakano 1Niigata Research Laboratory, Mitsubishi Gas Chemical Company, Inc., 182 Shinwari, Tayuhama, Kita-ku, Niigata 950-3112
  • Tetsuro Yamamoto TTC Co., Ltd., 1-20-2 Ebisunishi, Shibuya-ku, Tokyo 150-0021
  • Hisayoshi Okamura Cognitive and Molecular Institute of Brain Diseases, Kurume University, 67 Asahi-machi, Kurume, Fukuoka 830-0011
  • Akira Tsuda 4Department of Psychology, Kurume University, 1635 Miimachi, Kurume 839-8502
  • Yasuyuki Kowatari Ueno Clinic, Aisei Hospital, 2-18-6 Higashiueno, Taito-ku, Tokyo, 110-0015

DOI:

https://doi.org/10.31989/ffhd.v2i8.81

Abstract

Seventeen adult male and female subjects participated in a clinical trial using an open-label trial to evaluate the effectiveness of pyrroloquinoline quinone (PQQ) on stress, fatigue, quality of life and sleep. They ingested 20 mg of PQQ daily for 8 weeks. Changes in stress, fatigue, quality of life measures and sleep were evaluated using various inventories and questionnaires. For example, the results of the Profile of Mood States-Short Form revealed that all six measures of vigor, fatigue, tension-anxiety, depression, anger-hostility and confusion were significantly improved following PQQ administration compared with scores for those measures before administration of PQQ. Measures for quality of life, appetite, sleep, obsession and pain, also improved significantly. The results of the Oguri-Shirakawa-Azumi Sleep Inventory (Middle Aged and Aged version) showed significant improvement in sleepiness at awakening, sleep onset and maintenance, and sleep duration. For validation, the Pittsburgh Sleep Quality Index Japanese version also showed significant improvement in sleep-related behavior. Furthermore, the changes in these global scores were correlated with changes in the cortisol awakening response (R = -0.55), i.e. the effects of PQQ on improvement of sleep quality are supported by a biomarker.

Keywords: Pyrroloquinoline quinone, stress, fatigue, quality of life, sleep

Downloads

Published

2012-08-31

Issue

Vol. 2 No. 8 (2012): August 2012

Section

Research Articles

License

Any manuscripts or substantial parts of it, submitted to the journal must not be under consideration by or previously published in any other journal or citable form. Authors are required to ensure that no material submitted as part of a manuscript infringes existing copyrights or the rights of a third party. In submitting one's article in any form, the author has assigned the FFC publishing rights and has agreed to an automatic transfer of the copyright to the publisher. This is so that the FFC may create print option journals, for example, at the FFC’s discretion. If the author wishes to distribute their works by means outside of the FFC, for example within their community, they will have to place a request. 

 

Correspondence concerning articles published in Functional Foods in Health and Disease is encouraged. While derivative works (adaptations, extensions on the current work, etc.) are allowed, distribution of the modified material is not allowed without permission from the FFC.